288 related articles for article (PubMed ID: 21940152)
1. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
[TBL] [Abstract][Full Text] [Related]
2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
3. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
Carlberg L; Schosser A; Calati R; Serretti A; Massat I; Papageorgiou K; Kocabas NA; Mendlewicz J; Zohar J; Montgomery SA; Souery D; Kasper S
Int J Neurosci; 2015 May; 125(5):336-43. PubMed ID: 24955721
[TBL] [Abstract][Full Text] [Related]
4. The association of single nucleotide polymorphisms in the catechol-O-methyltransferase gene and pain scores in female patients with major depressive disorder.
Fijal B; Perlis RH; Heinloth AN; Houston JP
J Pain; 2010 Sep; 11(9):910-5, 915.e1-9. PubMed ID: 20627703
[TBL] [Abstract][Full Text] [Related]
5. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
[TBL] [Abstract][Full Text] [Related]
6. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Int Clin Psychopharmacol; 2016 Jan; 31(1):1-7. PubMed ID: 26544898
[TBL] [Abstract][Full Text] [Related]
7. The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.
Schosser A; Carlberg L; Calati R; Serretti A; Massat I; Spindelegger C; Linotte S; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
Int J Neuropsychopharmacol; 2017 Oct; 20(10):782-787. PubMed ID: 28977521
[TBL] [Abstract][Full Text] [Related]
8. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
[TBL] [Abstract][Full Text] [Related]
9. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
10. The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2013 Aug; 263(5):385-91. PubMed ID: 23081704
[TBL] [Abstract][Full Text] [Related]
11. Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study.
Calati R; Porcelli S; Giegling I; Hartmann AM; Möller HJ; De Ronchi D; Serretti A; Rujescu D
J Psychiatr Res; 2011 Mar; 45(3):309-21. PubMed ID: 20667552
[TBL] [Abstract][Full Text] [Related]
12. Somatization in major depression--clinical features and genetic associations.
Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
[TBL] [Abstract][Full Text] [Related]
13. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.
Massat I; Souery D; Del-Favero J; Nothen M; Blackwood D; Muir W; Kaneva R; Serretti A; Lorenzi C; Rietschel M; Milanova V; Papadimitriou GN; Dikeos D; Van Broekhoven C; Mendlewicz J
Mol Psychiatry; 2005 Jun; 10(6):598-605. PubMed ID: 15583702
[TBL] [Abstract][Full Text] [Related]
14. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine.
Tourian KA; Padmanabhan K; Groark J; Ninan PT
J Clin Psychopharmacol; 2010 Aug; 30(4):411-6. PubMed ID: 20631558
[TBL] [Abstract][Full Text] [Related]
16. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
17. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
[TBL] [Abstract][Full Text] [Related]
18. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
19. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
20. Association of the COMT val158met variant with antidepressant treatment response in major depression.
Baune BT; Hohoff C; Berger K; Neumann A; Mortensen S; Roehrs T; Deckert J; Arolt V; Domschke K
Neuropsychopharmacology; 2008 Mar; 33(4):924-32. PubMed ID: 17522626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
